06.23.20FDA Grants Premarket Approval for Neurostimulation System for Chronic Back Pain
06.17.20Galcanezumab Reduces Episodic and Chronic Migraine Pain Burden
06.16.20National Headache Foundation Survey Shows People With Migraine Feel Misunderstood
06.15.20Eptinezumab Reduced Use of Acute Migraine Treatments and Resolved Medication Overuse Headache
06.11.20Dihydroergotamine Delivered to Upper Nasal Cavity is Safe and Effective for Acute Migraine Treatment
06.08.20Phase 2 Clinical Trial of LSD for Cluster Headaches Initiated
Teleneurology Billing and Coding
Perspectives on coding evaluation & management during the COVID-19 pandemic.
Brad Klein, MD, MBA, FAAN, FAHS, FAANEM, and Raissa Villanueva MD, MPH, FAAN
Something can almost always be offered virtually for people with neuro-ophthalmologic conditions.
Melissa W. Ko, MD; Kevin E. Lai, MD; and Devin D. Mackay, MD
Teleneurology for Primary Headache Disorders
During the COVID-19 public health emergency, remote and in-person care for headache disorders is necessary to reduce patient risk.
Jennifer Robblee, MD, MSc; Amaal J. Starling, MD; Rashmi B. Halker Singh, MD, FAHS, FAAN; and Nina Riggins, MD, PhD
Chief Medical Editor's Page
COVID-19: A Tele- All Exposé
Stephen M. Gollomp, MD, and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
05.21.20FDA Approves Dihydroergotamine Mesylate Nasal Spray With Competitive Generic Therapy Designation
05.18.20Efficacy, Safety, Tolerability, and Pharmacoeconomic Value Data for Rimegepant Presented
05.15.20AAN Position Statement Recommends Teleneurology for Nonurgent Neurologic Care During COVID-19 Pandemic
Successfully treating medication-overuse headache requires also treating any comorbid conditions or worsening primary headache disorder.
Jessica Ailani, MD, FAHS, FAAN
Secondary Headaches During Pregnancy and the Postpartum Period
A new or markedly different headache in pregnancy or the postpartum period warrants neuroimaging to rule out secondary causes of headache.
Katherine T. Hamilton, MD
Posttraumatic Headache in Children
Headache is common—although usually transient—in children after traumatic brain injury; therapy includes pharmacologic, behavioral, and educational interventions.
Elizabeth Ackley, MD, and Marcy E. Yonker, MD, FAHS
Giant Cell Arteritis
Headache occurs in 70% to 80% of people with giant cell arteritis.
Britany Klenofsky, MD, and Huma U. Sheikh, MD
Some cardiac workup is a necessary part of headache evaluation to assess for secondary headache and potential risks of available headache treatments.
Deena E. Kuruvilla, MD, FAHS
Spontaneous Intracranial Hypotension
Spontaneous intracranial hypotension requires a high index of suspicion because of potentially normal diagnostic test results and refractory symptoms.
Jennifer Robblee, MD, MSc; Karissa A. Secora, PA-C; Lea M. Alhilali, MD; and Kerry L. Knievel, DO